Kevin K Buckbee sold $310K of AbbVie (ABBV)

Executed Dec 16 2024, disclosed Dec 18 2024, 2 days later.

Value, as filed

$310K

1,800 sh × $172.24

Executed

Dec 16 2024

the trade date, as filed

Disclosed

Dec 18 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KB Kevin K Buckbee SVP, CONTROLLER profile →

Kevin K Buckbee (SVP, CONTROLLER) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in AbbVie Inc. (ABBV). The largest single filing was $3.9M of ABBV (18,944 sh across 2 lots, as filed), executed Feb 26 2025.

The name

ABBV AbbVie Inc. ABBV · Healthcare · 41 filings in 24 months ticker →

Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kevin K Buckbee in ABBV

ABBVSALE AbbVie Inc. $3.9M
18,944 sh across 2 lots
Exec Feb 26 2025
Filed Feb 28 2025 · 5:30 PM ET